136 related articles for article (PubMed ID: 29669234)
1. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Nikolaev SI; Fish JE; Radovanovic I
N Engl J Med; 2018 Apr; 378(16):1561-1562. PubMed ID: 29669234
[No Abstract] [Full Text] [Related]
2. High prevalence of KRAS/BRAF somatic mutations in brain and spinal cord arteriovenous malformations.
Hong T; Yan Y; Li J; Radovanovic I; Ma X; Shao YW; Yu J; Ma Y; Zhang P; Ling F; Huang S; Zhang H; Wang Y
Brain; 2019 Jan; 142(1):23-34. PubMed ID: 30544177
[TBL] [Abstract][Full Text] [Related]
3. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Morita H; Komuro I
N Engl J Med; 2018 Apr; 378(16):1561. PubMed ID: 29671469
[No Abstract] [Full Text] [Related]
4. Somatic Activating KRAS Mutations in Arteriovenous Malformations of the Brain.
Nikolaev SI; Vetiska S; Bonilla X; Boudreau E; Jauhiainen S; Rezai Jahromi B; Khyzha N; DiStefano PV; Suutarinen S; Kiehl TR; Mendes Pereira V; Herman AM; Krings T; Andrade-Barazarte H; Tung T; Valiante T; Zadeh G; Tymianski M; Rauramaa T; Ylä-Herttuala S; Wythe JD; Antonarakis SE; Frösen J; Fish JE; Radovanovic I
N Engl J Med; 2018 Jan; 378(3):250-261. PubMed ID: 29298116
[TBL] [Abstract][Full Text] [Related]
5. KRAS Activating Signaling Triggers Arteriovenous Malformations.
Cheng F; Nussinov R
Trends Biochem Sci; 2018 Jul; 43(7):481-483. PubMed ID: 29748115
[TBL] [Abstract][Full Text] [Related]
6. Somatic Gain of KRAS Function in the Endothelium Is Sufficient to Cause Vascular Malformations That Require MEK but Not PI3K Signaling.
Fish JE; Flores Suarez CP; Boudreau E; Herman AM; Gutierrez MC; Gustafson D; DiStefano PV; Cui M; Chen Z; De Ruiz KB; Schexnayder TS; Ward CS; Radovanovic I; Wythe JD
Circ Res; 2020 Aug; 127(6):727-743. PubMed ID: 32552404
[TBL] [Abstract][Full Text] [Related]
7. KRAS G12D or G12V Mutation in Human Brain Arteriovenous Malformations.
Oka M; Kushamae M; Aoki T; Yamaguchi T; Kitazato K; Abekura Y; Kawamata T; Mizutani T; Miyamoto S; Takagi Y
World Neurosurg; 2019 Jun; 126():e1365-e1373. PubMed ID: 30902772
[TBL] [Abstract][Full Text] [Related]
8. Activating KRAS mutations in arteriovenous malformations of the brain: frequency and clinicopathologic correlation.
Priemer DS; Vortmeyer AO; Zhang S; Chang HY; Curless KL; Cheng L
Hum Pathol; 2019 Jul; 89():33-39. PubMed ID: 31026472
[TBL] [Abstract][Full Text] [Related]
9. KRAS/BRAF mutations in brain arteriovenous malformations: A systematic review and meta-analysis.
Bameri O; Salarzaei M; Parooie F
Interv Neuroradiol; 2021 Aug; 27(4):539-546. PubMed ID: 33401991
[TBL] [Abstract][Full Text] [Related]
10. Arteriovenous malformation phenotype resembling congenital hemangioma contains KRAS mutations.
Sudduth CL; McGuire AM; Smits PJ; Konczyk DJ; Al-Ibraheemi A; Fishman SJ; Greene AK
Clin Genet; 2020 Dec; 98(6):595-597. PubMed ID: 32799314
[TBL] [Abstract][Full Text] [Related]
11. Arteriovenous malformation associated with a HRAS mutation.
Konczyk DJ; Goss JA; Smits PJ; Huang AY; Al-Ibraheemi A; Sudduth CL; Warman ML; Greene AK
Hum Genet; 2019 Dec; 138(11-12):1419-1421. PubMed ID: 31637524
[TBL] [Abstract][Full Text] [Related]
12. Mosaic GNA11 mutations and a second hit in KRAS in phakomatosis pigmentovascularis are associated with intraosseous arteriovenous malformations in the jaw.
Sun Y; Su L; Rao Y; Wang Z; Wang D; Fan X; Cai 蔡韧 R
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):e484-e486. PubMed ID: 35080323
[No Abstract] [Full Text] [Related]
13. Somatic mutational landscape of extracranial arteriovenous malformations and phenotypic correlations.
El Sissy FN; Wassef M; Faucon B; Salvan D; Nadaud S; Coulet F; Adle-Biassette H; Soubrier F; Bisdorff A; Eyries M
J Eur Acad Dermatol Venereol; 2022 Jun; 36(6):905-912. PubMed ID: 35238086
[TBL] [Abstract][Full Text] [Related]
14. Genotype-guided targeted treatment of KRAS-mutated arteriovenous malformations.
Cai R; Wang Z; Sun Y; Yang X; Wen M; Zheng L; Wang D; Yu L; Fan X; Su L
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):e708-e710. PubMed ID: 35445448
[No Abstract] [Full Text] [Related]
15. Parkes Weber syndrome with lymphedema caused by a somatic
Eng W; Sudduth CL; Konczyk DJ; Smits PJ; Taghinia AH; Fishman SJ; Alomari A; Adams DM; Greene AK
Cold Spring Harb Mol Case Stud; 2021 Dec; 7(6):. PubMed ID: 34607843
[TBL] [Abstract][Full Text] [Related]
16. Intramuscular fast-flow vascular anomaly contains somatic MAP2K1 and KRAS mutations.
Goss JA; Konczyk DJ; Smits PJ; Kozakewich HPW; Alomari AI; Al-Ibraheemi A; Taghinia AH; Dickie BH; Adams DM; Fishman SJ; Mulliken JB; Warman ML; Greene AK
Angiogenesis; 2019 Nov; 22(4):547-552. PubMed ID: 31486960
[TBL] [Abstract][Full Text] [Related]
17. Review of treatment and therapeutic targets in brain arteriovenous malformation.
Pan P; Weinsheimer S; Cooke D; Winkler E; Abla A; Kim H; Su H
J Cereb Blood Flow Metab; 2021 Dec; 41(12):3141-3156. PubMed ID: 34162280
[TBL] [Abstract][Full Text] [Related]
18. De Novo Germline and Somatic Variants Convergently Promote Endothelial-to-Mesenchymal Transition in Simplex Brain Arteriovenous Malformation.
Li H; Nam Y; Huo R; Fu W; Jiang B; Zhou Q; Song D; Yang Y; Jiao Y; Weng J; Yan Z; Di L; Li J; Wang J; Xu H; Wang S; Zhao J; Wen Z; Wang J; Cao Y
Circ Res; 2021 Oct; 129(9):825-839. PubMed ID: 34530633
[TBL] [Abstract][Full Text] [Related]
19. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
[TBL] [Abstract][Full Text] [Related]
20. Monitoring Arteriovenous Malformation Response to Genotype-Targeted Therapy.
Edwards EA; Phelps AS; Cooke D; Frieden IJ; Zapala MA; Fullerton HJ; Shimano KA
Pediatrics; 2020 Sep; 146(3):. PubMed ID: 32859736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
